CSL books $US2b profit despite ‘sobering’ COVID conditions
MELBOURNE: Biotechnology giant CSL has booked a $US2 billion ($2.8 billion) full year profit and
MELBOURNE: Biotechnology giant CSL has booked a $US2 billion ($2.8 billion) full year profit and